DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
Prague JK, Roberts RE, Comninos AN. , et al.
Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
Lancet 2017;
389 (10081): 1809-1820
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.